katerzia logo mixed - landscape
A parent holds their child in the air above their shoulders
Actor Portrayal

What Is Hypertension?

If you have ever had your blood pressure measured, you have probably noticed that the reading consists of 2 numbers.

Katerzia droplet bullet icon
The first, higher number indicates the pressure in your bloodstream when your heart is contracting and pushing out blood. This is called your systolic blood pressure
Katerzia droplet bullet icon
The second, lower number indicates the pressure in your bloodstream between beats and is referred to as your diastolic blood pressure
Katerzia droplet bullet icon
The Centers for Disease Control and Prevention considers a diagnosis of "hypertension" to mean that either or both numbers are in the top 5% for your age group.
Purple blood pressure monitor for checking hypertension in children

Hypertension is common enough in children and teens that the American Academy of Pediatrics (AAP) recommends that blood pressure be measured annually in all children and teens starting at 3 years old.

icon pressure cuff

How Is Hypertension
Diagnosed in Children?

This free download from the National Institutes of Health outlines how pediatric hypertension is diagnosed and lists ideal blood pressure targets by age.
Download
Katerzia icon mail

Stay Up to Date on the Latest 
News About Katerzia

Sign up here to join fellow patients, parents, and providers on our secure mailing list for news and updates relating to Katerzia and pediatric hypertension.
Sign Up
A young girl with hypertension symptoms looks at the camera
Actor Portrayal

The Silent Threat

According to both the American Heart Association and the Cleveland Clinic, high blood pressure, whether in children, teens, or adults, does not always present with recognizable symptoms. Persistent high blood pressure can cause lasting damage to the kidneys, heart, vasculature, and brain, even when no symptoms are present.

One of the most visible danger signs for high blood pressure risk is being overweight. The Cleveland Clinic and the AAP's Subcommittee on Screening and Management of High Blood Pressure in Children have both reported that in children, elevated body weight and high blood pressure generally present together.

Other warning signs of hypertension include

Katerzia droplet bullet icon
Headaches
Katerzia droplet bullet icon
Shortness of breath
Katerzia droplet bullet icon
Nosebleeds
Katerzia droplet bullet icon
Behavior changes

Ask your HCP about conditions under which a child aged 6 years and older should be monitored for high blood pressure. Conditions include:

Katerzia droplet bullet icon
Recurring urinary tract infection
Katerzia droplet bullet icon
Blood in urine
Katerzia droplet bullet icon
Excessive protein in urine
Katerzia droplet bullet icon
Diagnosis of kidney disease
Katerzia droplet bullet icon
Malformations of the urinary tract
Katerzia droplet bullet icon
Use of medications known to raise blood pressure
Katerzia droplet bullet icon
Family history of kidney disease
Katerzia droplet bullet icon
Premature birth, very low birth weight, history of 
neonatal intensive care
Katerzia droplet bullet icon
Congenital heart disease (repaired or not)
Katerzia droplet bullet icon
Cancer
Katerzia droplet bullet icon
Recipients of organ or bone marrow transplant
Katerzia droplet bullet icon
Diagnosis of neurofibromatosis, tuberous sclerosis, or Marfan syndrome

Did you know that Azurity Pharmaceuticals offers many FDA-approved liquid formulations? Visit Azurity.com to learn more.

Go Now

IMPORTANT SAFETY INFORMATION

KATERZIA® (amlodipine) Oral Suspension, 1 mg/mL

INDICATIONS

  • KATERZIA is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:

  • Hypertension in adults and children 6 years of age and older to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

  • Coronary Artery Disease:
    • Chronic stable angina.
    • Vasospastic angina (Prinzmetal’s or Variant Angina).
    • Angiographically documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%.

A calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device. Ask your pharmacist or doctor for assistance in selecting a measuring device. Shake well before using.

ADDITIONAL IMPORTANT SAFETY INFORMATION

Do not use KATERZIA if you are allergic to amlodipine.

What is the most important information I should know about KATERZIA?
KATERZIA may cause serious side effects, including:

  • Low blood pressure: Symptoms of low blood pressure (hypotension) are possible, particularly in patients with serious heart valve disease (severe aortic stenosis). However, acute low blood pressure is unlikely.

  • Increased chest pain or heart attack: Worsening chest pain called angina, and heart attack (acute myocardial infarction) can develop after starting or increasing the dose of Katerzia, particularly in patients with severe obstructive coronary artery disease.

  • Patients with severe liver disease: Patients with severe liver disease may need to start with a lower initial dose of Katerzia.

Before taking KATERZIA, tell your healthcare provider about all your medical conditions, including if you:

  • ever had heart disease
  • ever had liver problems
  • are pregnant or plan to become pregnant. Your doctor will decide if KATERZIA is the best treatment for you.
  • are breastfeeding. Do not breastfeed while taking KATERZIA. You can stop breastfeeding or take a different medicine.


Tell your healthcare provider about all your medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Tell your doctor if you are taking simvastatin, cyclosporine, or tacrolimus. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

The most common side effect of KATERZIA is swelling (edema), which occurs in a dose-related manner. Other adverse experiences not dose-related but reported with an incidence >1.0 % are tiredness, nausea, abdominal pain, and sleepiness.

Store KATERZIA at refrigerated temperature (2°C to 8°C/36°F to 46°F). Avoid freezing and excessive heat. Protect from light.

The Important Safety Information does not include all the information needed to use KATERZIA safely and effectively. Please talk to your healthcare provider and see the complete Prescribing Information for KATERZIA.
To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1-800-461-7449 or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.
Product labeling, packaging, and imagery are for representation purposes only.

Healthcare provider and patient images on this website are not actual healthcare providers and patients.

The Information contained herein, including product information, is intended only for residents of the United States.

© 2024 Azurity Pharmaceuticals, Inc. All Rights Reserved. All Trademarks referred to are the property of their respective owners.
PP-KAT-US-0059

IMPORTANT SAFETY INFORMATION

KATERZIA® (amlodipine) Oral Suspension, 1 mg/mL

INDICATIONS

KATERZIA is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:

See More

IMPORTANT SAFETY INFORMATION

KATERZIA® (amlodipine) Oral Suspension, 1 mg/mL

INDICATIONS

  • KATERZIA is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:

  • Hypertension in adults and children 6 years of age and older to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

  • Coronary Artery Disease:
    • Chronic stable angina.
    • Vasospastic angina (Prinzmetal’s or Variant Angina).
    • Angiographically documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%.

A calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device. Ask your pharmacist or doctor for assistance in selecting a measuring device. Shake well before using.

ADDITIONAL IMPORTANT SAFETY INFORMATION

Do not use KATERZIA if you are allergic to amlodipine.

What is the most important information I should know about KATERZIA?
KATERZIA may cause serious side effects, including:

  • Low blood pressure: Symptoms of low blood pressure (hypotension) are possible, particularly in patients with serious heart valve disease (severe aortic stenosis). However, acute low blood pressure is unlikely.

  • Increased chest pain or heart attack: Worsening chest pain called angina, and heart attack (acute myocardial infarction) can develop after starting or increasing the dose of Katerzia, particularly in patients with severe obstructive coronary artery disease.

  • Patients with severe liver disease: Patients with severe liver disease may need to start with a lower initial dose of Katerzia.

Before taking KATERZIA, tell your healthcare provider about all your medical conditions, including if you:

  • ever had heart disease
  • ever had liver problems
  • are pregnant or plan to become pregnant. Your doctor will decide if KATERZIA is the best treatment for you.
  • are breastfeeding. Do not breastfeed while taking KATERZIA. You can stop breastfeeding or take a different medicine.


Tell your healthcare provider about all your medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Tell your doctor if you are taking simvastatin, cyclosporine, or tacrolimus. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

The most common side effect of KATERZIA is swelling (edema), which occurs in a dose-related manner. Other adverse experiences not dose-related but reported with an incidence >1.0 % are tiredness, nausea, abdominal pain, and sleepiness.

Store KATERZIA at refrigerated temperature (2°C to 8°C/36°F to 46°F). Avoid freezing and excessive heat. Protect from light.

The Important Safety Information does not include all the information needed to use KATERZIA safely and effectively. Please talk to your healthcare provider and see the complete Prescribing Information for KATERZIA.
To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1-800-461-7449 or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.